Promakhos Therapeutics
Private Company
Creating transformative medicines for patients with inflammatory diseases.
Biotechnology Research
Boston, Massachusetts
2-10 employees
Founded 2021
About Promakhos Therapeutics
Promakhos Therapeutics is a biotechnology company developing transformative medicines for people with inflammatory diseases. Their therapies aim to address the root cause of conditions like Crohn's disease and multiple sclerosis by restoring the immune system's natural ability to manage inflammation and heal. The company targets both patients suffering from these chronic conditions and partners within the biomedical research and pharmaceutical industries.
Company Classification
Customer Types
B2B
Business Models
ProductsLicensing
Product & Service Types
Immune-restorative therapiesTreatments for inflammatory diseases
Funding
Total Funding
$125.0K
No. of Funding Rounds
3
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos